# US 6,730,661 B1 · Nutritional composition which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,661 B1
- Document ID: US6730661B1
- Status: Granted
- Kind: B1
- Application number: 10/089,371
- Filed: 2002-07-16
- Granted: 2004-05-04
- Earliest claimed: 1999-09-29
- Assignees: N. V. Nutricia
- Inventors: Amanda Johanne Kiliaan; Jacques Alphons Groot; Johannes Wilhelmus Timmermans; Jan Van Der Meulen; Katrien Maria Jozefa Van Laere; Pieter Brandt Bijlsma
- Web page: https://patentgrep.com/patent/US6730661B1

## CPC

- A23K 20/163: Sugars; Polysaccharides
- A23K 50/00: Feeding-stuffs specially adapted for particular animals
- A23K 50/60: for weanlings
- A23L 29/238: from seeds, e.g. locust bean gum or guar gum (starch A23L29/212; pectin A23L29/231)
- A23L 29/244: from corms, tubers or roots, e.g. glucomannan (starch A23L29/212)
- A23L 29/273: {Dextran; Polysaccharides produced by leuconostoc}
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A61K 31/721: Dextrans
- A61K 31/736: Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/12: Antidiarrhoeals
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23K: FODDER
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention relates to the use of one or more non-digestible polysaccharides selected from the group consisting of dextrans having a molecular weight of 8 kD to 40,000 kD, hydrolysed (gluco)mannans having a molecular weight of 0.5 kD to 1,000 kD and hydrolysed (galacto) mannans having a molecular weigth of 0.5 kD to 1,000 kD for the preparation of a nutritional composition to reduce the uptake of high molecular weight substances, allergens and microorganisms through the intestinal wall, more particularly to reduce transport of high molecular weight substances, allergens and microorganisms through the tight junctions in the intestines, the rise in the viscosity of the nutritional composition caused by the polysaccharides being less than 20 mPa.s. The nutritional compositions can be used to prevent or to treat allergy, allergic reactions, sepsis and inflammatory processes, such as can arise under emotional and physical stress, ischaemia, reperfusion damage during and after operations, after radiation treatment and/or chemotherapy of cancer patients and in the case of inflammatory diseases of the intestine, diarrhoea and allergies.

## Claims

### Claim 1

A method of reducing the uptake of molecular weight substances above 4000 Da, allergens and microorganisms through the intestinal wall, comprising administering to a mammal in need thereof a nutritional composition containing a polysaccharide selected from the group consisting of dextrans having a molecular weight of 8 kD to 40,000 kD, hydrolysed glucomannans having a molecular weight of 0.5 kD to 1,000 kD and hydrolysed galactomannans other than guar gum or hydrolysed guar gum, having a molecular weight of 0.5 kD to 1,000 kD, the polysaccharide being present in the nutritional composition only in an amount to cause an increase in the viscosity of the nutritional composition which is less than 10 m.Pa.s.

### Claim 2 (depends on 1)

A method as claimed in claim 1, wherein the polysaccharide is selected from dextrans having a molecular weight of 20 kD to 2,000 kD.

### Claim 3 (depends on 1)

A method as claimed in claim 1, wherein the nutritional composition is a complete food.

### Claim 4 (depends on 1)

A method as claimed in claim 1, wherein the nutritional composition is a food supplement.

### Claim 5 (depends on 1)

A method as claimed in claim 1, wherein the uptake reduction occurs at the tight junctions of the intestinal wall.

### Claim 6 (depends on 1)

A method as claimed in claim 1, wherein said mammal suffers from allergies, allergic reactions, and inflammatory processes, which can arise under emotional and physical stress, ischaemia, reperfusion damage during and after operations, and after radiation treatment and/or chemotherapy of cancer patients.

### Claim 7 (depends on 1)

A method as claimed in claim 1, wherein the nutritional composition is administered in a quantity such that the concentration of polysaccharide in the intestine is 0.1 to 6 g/l.
